Company profile: HighRes Biosolutions
1.1 - Company Overview
Company description
- Provider of modular laboratory automation systems and software for pharmaceutical, biotech, and academic research labs. Designs and builds innovative robotic systems and devices, including Nucleus hardware, Cellario integration software, MicroDock & MicroCart, CoLAB Flex collaborative robots, automated sample storage, and ancillary devices. Founded in 2004, headquartered in Woburn, Massachusetts.
Products and services
- Cellario: Enterprise-grade software that integrates all devices and software within a laboratory, adaptable to changes in science, technology, and organizational needs, supporting manual to enterprise-level automation
- Nucleus: Modular line of standardized hardware engineered for laboratory automation, enabling device distribution, system componentry, and sample distribution
- CoLAB Flex: Industrial-grade mobile, collaborative robotic system delivering vertical integration for high device density in a compact footprint, scalable as scientific needs evolve
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HighRes Biosolutions
Univercells
HQ: Belgium
Website
- Description: Provider of end-to-end, high-density, low-cost biomanufacturing solutions, including the NevoLine vaccine platform (incl. inactivated polio vaccine), scale-X single-use bioreactors, Exothera viral vector CDMO, custom bioproduction hubs with preclinical to commercial GMP capabilities, turnkey advisory for local site design/operation/regulatory compliance, and Ntensify RNA production in mobile labs; engineered to cut investments >75% and cost of goods up to 90%.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Univercells company profile →
Nanoplex Technologies
HQ: United States
Website
- Description: Provider of nanoparticle-based products for life science research, enabling ultra-sensitive molecular identification and quantitation, as well as authentication and tracking applications; focused on rapidly translating state-of-the-art nanoscience into practical, valuable products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanoplex Technologies company profile →
Molecubes
HQ: Belgium
Website
- Description: Provider of preclinical imaging cubes combining SPECT, PET, and CT for small-animal whole-body imaging. Solutions include X-CUBE micro-CT (high-resolution), β-CUBE micro-PET (high sensitivity and resolution), and γ-CUBE SPECT (high-sensitivity, high-resolution, patented technology). Also offers CUBEFLOW software for streamlined imaging workflows and REMI reconstruction engine for simultaneous and batch processing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecubes company profile →
Healionics
HQ: United States
Website
- Description: Provider of synthetic vascular grafts and platform biomaterial scaffolds for dialysis patients and tissue regeneration. Offers STARgraft for reliable bloodstream access with resistance to occlusion and infection, and STAR Biomaterial with specific pore structure to enable angiogenesis and minimize foreign body response.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Healionics company profile →
SQZ Biotech
HQ: United States
Website
- Description: Provider of cell engineering technology designed to deliver a diverse set of materials into patient cells and to develop cellular therapies for multiple indications using proprietary CellSqueeze technology, advanced through internal research programs and external partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SQZ Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HighRes Biosolutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HighRes Biosolutions
2.2 - Growth funds investing in similar companies to HighRes Biosolutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HighRes Biosolutions
4.2 - Public trading comparable groups for HighRes Biosolutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →